Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
74.55
-0.65 (-0.86%)
At close: Sep 18, 2025, 4:00 PM EDT
74.55
0.00 (0.00%)
After-hours: Sep 18, 2025, 5:01 PM EDT
Edwards Lifesciences Employees
Edwards Lifesciences had 15,800 employees as of December 31, 2024. The number of employees decreased by 4,000 or -20.20% compared to the previous year.
Employees
15,800
Change (1Y)
-4,000
Growth (1Y)
-20.20%
Revenue / Employee
$359,816
Profits / Employee
$262,506
Market Cap
43.77B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15,800 | -4,000 | -20.20% |
Dec 31, 2023 | 19,800 | 2,500 | 14.45% |
Dec 31, 2022 | 17,300 | 1,600 | 10.19% |
Dec 31, 2021 | 15,700 | 800 | 5.37% |
Dec 31, 2020 | 14,900 | 1,000 | 7.19% |
Dec 31, 2019 | 13,900 | 1,100 | 8.59% |
Dec 31, 2018 | 12,800 | 600 | 4.92% |
Dec 31, 2017 | 12,200 | 1,100 | 9.91% |
Dec 31, 2016 | 11,100 | 1,300 | 13.27% |
Dec 31, 2015 | 9,800 | 700 | 7.69% |
Dec 31, 2014 | 9,100 | 500 | 5.81% |
Dec 31, 2013 | 8,600 | 400 | 4.88% |
Dec 31, 2012 | 8,200 | 400 | 5.13% |
Dec 31, 2011 | 7,800 | 800 | 11.43% |
Dec 31, 2010 | 7,000 | 600 | 9.38% |
Dec 31, 2009 | 6,400 | 200 | 3.23% |
Dec 31, 2008 | 6,200 | 600 | 10.71% |
Dec 31, 2007 | 5,600 | 50 | 0.90% |
Dec 31, 2006 | 5,550 | 150 | 2.78% |
Dec 31, 2005 | 5,400 | 200 | 3.85% |
Dec 31, 2004 | 5,200 | 200 | 4.00% |
Dec 31, 2003 | 5,000 | 0 | - |
Dec 31, 2002 | 5,000 | 189 | 3.93% |
Dec 31, 2001 | 4,811 | -289 | -5.67% |
Dec 31, 2000 | 5,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EW News
- 20 days ago - Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care - Business Wire
- 4 weeks ago - Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase - Business Wire
- 5 weeks ago - Edwards Lifesciences Corporation Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 5 weeks ago - Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025 - Seeking Alpha
- 6 weeks ago - JenaValve Responds to FTC's Action Against Proposed Edwards Lifesciences Acquisition - GlobeNewsWire
- 6 weeks ago - FTC seeks to block Edwards Lifesciences' acquisition of JenaValve - Reuters
- 6 weeks ago - Edwards Lifesciences Comments on FTC's Action to Block Proposed Acquisition of JenaValve - Business Wire
- 6 weeks ago - Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027 - Benzinga